AR017097A1 - COMPOUNDS OF 2- (3H) -OXAZOLONA, USEFUL AS SELECTIVE COX-2 INHIBITORS; PROCEDURE TO PREPARE SUCH COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS FORMED WITH SUCH COMPOUNDS - Google Patents
COMPOUNDS OF 2- (3H) -OXAZOLONA, USEFUL AS SELECTIVE COX-2 INHIBITORS; PROCEDURE TO PREPARE SUCH COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS FORMED WITH SUCH COMPOUNDSInfo
- Publication number
- AR017097A1 AR017097A1 ARP980104535A ARP980104535A AR017097A1 AR 017097 A1 AR017097 A1 AR 017097A1 AR P980104535 A ARP980104535 A AR P980104535A AR P980104535 A ARP980104535 A AR P980104535A AR 017097 A1 AR017097 A1 AR 017097A1
- Authority
- AR
- Argentina
- Prior art keywords
- compounds
- useful
- pharmaceutical compositions
- inhibitors
- oxazolona
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D263/34—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D263/36—One oxygen atom
- C07D263/38—One oxygen atom attached in position 2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pulmonology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Abstract
Se trata de compuestos de 2-(3H)-oxazolona de formula (I) donde: r1 es alquilo o un grupo amino; R2 es naftilo, un grupo fenilo o fenilo no sustituido,sustituido desde 1 a 3 átomos de halogeno o alquilo, alcoxi o grupos trifluorometilo; y R3 es hidrogeno o un grupo alquilo. Dichos compuestos son utiles comoinhibidores selectivos de la COX-2 (ciclooxigenasa-2), utiles para el tratamiento de enfermedades mediadas por la COX-2, sin la manifestacion de efectosulcerogénicos. También se propone un procedimiento para preparar dichos compuestos de formula (I), y composiciones farmacéuticas que los incluyen como agenteactivo.These are 2- (3H) -oxazolone compounds of formula (I) where: r1 is alkyl or an amino group; R2 is naphthyl, an unsubstituted phenyl or phenyl group, substituted from 1 to 3 halogen or alkyl, alkoxy or trifluoromethyl groups; and R3 is hydrogen or an alkyl group. These compounds are useful as selective inhibitors of COX-2 (cyclooxygenase-2), useful for the treatment of diseases mediated by COX-2, without the manifestation of ulcer effects. A process is also proposed for preparing said compounds of formula (I), and pharmaceutical compositions that include them as active agent.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ES009701928A ES2131015B1 (en) | 1997-09-12 | 1997-09-12 | NEW DERIVATIVES OF 2- (3H) -OXAZOLONE, PROCEDURES FOR ITS PREPARATION AND USE IN PHARMACEUTICAL COMPOSITIONS. |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR017097A1 true AR017097A1 (en) | 2001-08-22 |
Family
ID=8300586
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP980104535A AR017097A1 (en) | 1997-09-12 | 1998-09-11 | COMPOUNDS OF 2- (3H) -OXAZOLONA, USEFUL AS SELECTIVE COX-2 INHIBITORS; PROCEDURE TO PREPARE SUCH COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS FORMED WITH SUCH COMPOUNDS |
Country Status (10)
| Country | Link |
|---|---|
| EP (1) | EP1017685A1 (en) |
| JP (1) | JP2001516750A (en) |
| AR (1) | AR017097A1 (en) |
| AU (1) | AU9623698A (en) |
| CO (1) | CO5011110A1 (en) |
| ES (1) | ES2131015B1 (en) |
| PE (1) | PE116999A1 (en) |
| UY (1) | UY25179A1 (en) |
| WO (1) | WO1999014205A1 (en) |
| ZA (1) | ZA988303B (en) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6833373B1 (en) | 1998-12-23 | 2004-12-21 | G.D. Searle & Co. | Method of using an integrin antagonist and one or more antineoplastic agents as a combination therapy in the treatment of neoplasia |
| ES2166710B1 (en) * | 2000-04-25 | 2004-10-16 | J. URIACH & CIA, S.A. | NEW HETEROCICLIC COMPOUNDS WITH ANTI-INFLAMMATORY ACTIVITY. |
| US20030105144A1 (en) | 2001-04-17 | 2003-06-05 | Ping Gao | Stabilized oral pharmaceutical composition |
| US6673818B2 (en) | 2001-04-20 | 2004-01-06 | Pharmacia Corporation | Fluoro-substituted benzenesulfonyl compounds for the treatment of inflammation |
| ES2213485B1 (en) | 2003-02-13 | 2005-12-16 | Almirall Prodesfarma, S.A. | DERIVATIVES OF 2-FENILPIRAN-4-ONA. |
| IL305573A (en) | 2021-03-15 | 2023-10-01 | Saul Yedgar | HYALURONIC ACID-CONJUGATED DIPALMITOYL PHOSPHATIDYL ETHANOLAMINE IN COMBINATION WITH NON-STEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDs) FOR TREATING OR ALLEVIATING INFLAMMATORY DISEASES |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5380738A (en) * | 1993-05-21 | 1995-01-10 | Monsanto Company | 2-substituted oxazoles further substituted by 4-fluorophenyl and 4-methylsulfonylphenyl as antiinflammatory agents |
| WO1996036617A1 (en) * | 1995-05-19 | 1996-11-21 | G.D. Searle & Co. | Substituted oxazoles for the treatment of inflammation |
| ES2125161B1 (en) * | 1996-03-21 | 1999-11-16 | Grupo Farmaceutico Almirall S | NEW DERIVATIVES OF 2- (3H) -OXAZOLONA. |
| FR2753449B1 (en) * | 1996-09-13 | 1998-12-04 | Union Pharma Scient Appl | NOVEL 3,4-DIARYLOXAZOLONE DERIVATIVES, PROCESSES FOR THEIR PREPARATION, AND THERAPEUTIC USES |
-
1997
- 1997-09-12 ES ES009701928A patent/ES2131015B1/en not_active Expired - Fee Related
-
1998
- 1998-09-08 AU AU96236/98A patent/AU9623698A/en not_active Abandoned
- 1998-09-08 EP EP98950000A patent/EP1017685A1/en not_active Withdrawn
- 1998-09-08 JP JP2000511756A patent/JP2001516750A/en active Pending
- 1998-09-08 WO PCT/EP1998/005694 patent/WO1999014205A1/en not_active Application Discontinuation
- 1998-09-09 CO CO98051845A patent/CO5011110A1/en unknown
- 1998-09-10 ZA ZA988303A patent/ZA988303B/en unknown
- 1998-09-10 PE PE1998000863A patent/PE116999A1/en not_active Application Discontinuation
- 1998-09-11 UY UY25179A patent/UY25179A1/en not_active Application Discontinuation
- 1998-09-11 AR ARP980104535A patent/AR017097A1/en not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| JP2001516750A (en) | 2001-10-02 |
| ES2131015A1 (en) | 1999-07-01 |
| UY25179A1 (en) | 2000-12-29 |
| CO5011110A1 (en) | 2001-02-28 |
| EP1017685A1 (en) | 2000-07-12 |
| ES2131015B1 (en) | 2000-03-01 |
| ZA988303B (en) | 1999-03-11 |
| WO1999014205A1 (en) | 1999-03-25 |
| PE116999A1 (en) | 1999-12-13 |
| AU9623698A (en) | 1999-04-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR016762A1 (en) | 4-BROMO OR 4-IODINE PHENYLAMINE BENZOHIDROXAMIC ACID COMPOUNDS, PHARMACEUTICAL FORMULATIONS AND USE OF THE SAME | |
| NO146953C (en) | ANALOGY PROCEDURE FOR THE PREPARATION OF SUBSTITUTED PROPANOLAMINE AND MORPHOLINE DERIVATIVES | |
| AR245700A1 (en) | New derivatives of the 2-aniline-pyrimidine as anti-parasite agents. | |
| AR029301A1 (en) | COMPOUNDS DERIVED FROM BIARILO, METHODS FOR THEIR PREPARATION COMPOSITIONS THAT CONTAIN THEM, THEIR USE AS AGONISTS IN BETA-ADRENO-ATIPIC RECEIVERS | |
| ES2088933T3 (en) | DERIVATIVES OF PIRAZOLE, PROCEDURES FOR ITS PREPARATION AND PHARMACEUTICAL COMPOSITION THAT CONTAINS THEM. | |
| AR006720A1 (en) | A COMPOUND DERIVED FROM HETERO-CYCLIC AZAHEXANE, ITS USE FOR THE PREPARATION OF A PHARMACEUTICAL COMPOSITION, PROCEDURE FOR PREPARING IT AND A PHARMACEUTICAL COMPOSITION THAT INCLUDES IT | |
| AR005706A1 (en) | EGFR INHIBITORS OF 4-AMINOQUINZOLINE, PROCEDURE FOR THEIR OBTAINING, PHARMACEUTICAL COMPOSITION THAT CONTAINS THEM, USE OF THE SAME FOR THE PREPARATION OF A MEDICINE USEFUL AS AN ANTINEOPLASTIC AGENT | |
| DE60226875D1 (en) | ORTHOSUBSTITUTED ARYLAMIDES FOR COMBATING WIRELESS PESTS | |
| BR9307580A (en) | Process compounds for the preparation of the same pharmaceutical compositions use of a compound and process for the treatment of a mammal that includes humans | |
| BR0213646A (en) | Method, compounds and composition for invertebrate pest control | |
| ES2031876T3 (en) | A PROCEDURE FOR THE PREPARATION OF 5,6-DIHYDRO-2- (SUBSTITUTED PHENYL) -1,2,4, -TRIAZIN-3,5 (2H, 4H) -DIONAS. | |
| NZ503912A (en) | Piperidinylaminomethyl trifluoromethyl cyclic ether compounds and their use as substance P antagonists | |
| AR002711A1 (en) | A COMPOUND OF 2-CARBOXINDOL-3-SUBSTITUTED, A PROCESS FOR ITS PREPARATION, A NEW INTERMEDIATE COMPOUND FOR SUCH PROCESS, THE USE OF THE COMPOUND FOR THE MANUFACTURE OF A THERAPEUTIC AGENT AND A PHARMACEUTICAL COMPOSITION THAT INCLUDES SUCH A COMPOUND. | |
| NO871861D0 (en) | PROCEDURE FOR THE PREPARATION OF NEW DOPAMINE BETA-HYDROXYLASE INHIBITORS. | |
| PE20021018A1 (en) | DERIVATIVES OF ß - CARBOLINE | |
| EA200100090A2 (en) | New piperide-4-sulphonamide compounds, a process for their preparation and pharmaceutical compositions containing them | |
| ES2151254T3 (en) | 2- (3H) -OXAZOLONE DERIVATIVES AND THEIR USE AS COX-2 INHIBITORS. | |
| AR017097A1 (en) | COMPOUNDS OF 2- (3H) -OXAZOLONA, USEFUL AS SELECTIVE COX-2 INHIBITORS; PROCEDURE TO PREPARE SUCH COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS FORMED WITH SUCH COMPOUNDS | |
| DK0875506T3 (en) | Quinoline and quinazoline compounds useful for treatment | |
| PT99465A (en) | METHOD FOR PREPARING OXISULFONIL INHIBITORS UREIA ACIL-COA: CHOLESTEROL ACYL-TRANSFERASE (ACAT) | |
| PE20001067A1 (en) | DERIVATIVES OF 2-FENYLPYRAN-4-ONA | |
| AR035247A1 (en) | DERIVATIVES OF PIPERIDINACARBOXAMIDA, A PROCEDURE FOR ITS PREPARATION AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | |
| AR036028A1 (en) | PIRIMIDINE COMPOUND, PROCEDURE FOR PREPARATION, PHARMACEUTICAL COMPOSITIONS FORMULATED WITH SUCH COMPOUNDS AND USE OF COMPOUNDS IN THE PREPARATION OF THE MENTIONED COMPOSITIONS | |
| ATE191465T1 (en) | CARBAMOYLCARBONIC ACID AMIDES | |
| DK477783A (en) | 1,3,4,6,7-11B-HEXAHYDRO-7-ARYL-2H-PYRAZINO (2,1-A) -ISOQUINOLINES, METHOD FOR PREPARING IT AND THEIR USE AS INTERMEDIATES AND MEDICINAL PRODUCTS |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal |